These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10566028)

  • 1. Ibandronic acid. BM 210955, RPR 102289A, methylpentylaminopropylidene, Bondronat Bonviva.
    Drugs R D; 1999 Mar; 1(3):215-7. PubMed ID: 10566028
    [No Abstract]   [Full Text] [Related]  

  • 2. Risedronic acid. NE 58095, risedronate sodium, Actonel.
    Drugs R D; 1999 Mar; 1(3):218-20. PubMed ID: 10566029
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates.
    Muratore M; Quarta E; Grimaldi A; Calcagnile F; Quarta L
    Drug Des Devel Ther; 2011; 5():445-54. PubMed ID: 22087064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [News on osteoporosis: good effect of treatment with diphosphonates].
    Lakartidningen; 1997 Feb; 94(8):653-5. PubMed ID: 9072657
    [No Abstract]   [Full Text] [Related]  

  • 5. ALX 111. ALX1-11, PTH, parathyroid hormone (1-84)-Allelix, recombinant human parathyroid hormone, rhPTH(1-84).
    Drugs R D; 1999 Mar; 1(3):211-2. PubMed ID: 10566026
    [No Abstract]   [Full Text] [Related]  

  • 6. New drugs: entecavir, ibandronate sodium, and pegaptanib sodium.
    Hussar DA
    J Am Pharm Assoc (2003); 2005; 45(3):412-5. PubMed ID: 15991765
    [No Abstract]   [Full Text] [Related]  

  • 7. Trimegestone. RU 27987.
    Drugs R D; 1999 Mar; 1(3):228-9. PubMed ID: 10566033
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the efficacy and tolerance of ibandronic acid in patients with osteoarthrosis in the knee joints concurrent with osteoporosis: a pilot study].
    Alekseeva LI; Zaitseva EM; Sharapova EP; Taskina EA; Smirnov AV; Demin NV; Aleksandrova EN
    Ter Arkh; 2013; 85(5):30-6. PubMed ID: 23819336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
    Papapoulos SE
    Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
    [No Abstract]   [Full Text] [Related]  

  • 10. Ibandronic acid IV: new formulation. Unconvincing evidence.
    Prescrire Int; 2008 Feb; 17(93):10. PubMed ID: 18354845
    [No Abstract]   [Full Text] [Related]  

  • 11. [The successful development of bisphosphonates in the therapy of osteoporosis].
    Fassbender WJ; Stumpf UC; Kurth A
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibandronic acid: new drug. Osteoporosis: one tablet a month, but risk of a 'flu-like' syndrome.
    Prescrire Int; 2008 Feb; 17(93):11. PubMed ID: 18354857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis. Summary and table.
    Peters DC; Coleman SG
    Drugs R D; 1999 Mar; 1(3):203-9. PubMed ID: 10566025
    [No Abstract]   [Full Text] [Related]  

  • 14. Once-a-week risedronate (actonel).
    Med Lett Drugs Ther; 2002 Oct; 44(1141):87-8. PubMed ID: 12381968
    [No Abstract]   [Full Text] [Related]  

  • 15. CP 336156.
    Drugs R D; 1999 Mar; 1(3):213-4. PubMed ID: 10566027
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2005 Oct; 3(38):69-74. PubMed ID: 16177651
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucocorticoid-induced osteoporosis: prevention and treatment.
    Werth VP
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):84S-88S. PubMed ID: 9273946
    [No Abstract]   [Full Text] [Related]  

  • 18. Teriparatide. LY 333334, MN 10T, parathyroid hormone (1-34), parathyroid hormone (1-34)-Asahi, parathyroid hormone (1-34)-Eli Lilly, parathyroid hormone (1-34)-Rhône-Poulenc Rorer, teriparatide acetate, hPTH 1-34, Parathar.
    Drugs R D; 1999 Mar; 1(3):222-4. PubMed ID: 10566031
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of osteoporosis.
    Miller PD
    Adv Intern Med; 1999; 44():175-207. PubMed ID: 9929709
    [No Abstract]   [Full Text] [Related]  

  • 20. Once-monthly ibandronate for postmenopausal osteoporosis: review of a new dosing regimen.
    Pyon EY
    Clin Ther; 2006 Apr; 28(4):475-90. PubMed ID: 16750461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.